OPTIMIZING PARACEST AGENTS FOR HUMAN MR IMAGING
优化人类 MR 成像的辅助剂
基本信息
- 批准号:8363909
- 负责人:
- 金额:$ 1.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgarBindingBody partChemicalsChemistryCollaborationsComplexContrast MediaDetectionDevelopmentEquationFrequenciesFundingGadoliniumGrantHumanImageImaging TechniquesKnowledgeLanthanoid Series ElementsLigandsMagnetic Resonance ImagingMeasurementMetabolismMethodologyMethodsModificationNational Center for Research ResourcesPhysiologic pulsePrincipal InvestigatorPropertyRF coilRadionuclide ImagingRattusReagentRelaxationReportingResearchResearch InfrastructureResourcesSamplingSchemeSeriesSideSignal TransductionSourceStructureTimeTissuesUnited States National Institutes of HealthWaterabsorptionbasecostgadolinium oxideimaging modalityimprovedin vivoiron oxideirradiationmembermillisecondmolecular imagingoptical imagingparticlephosphonatesoft tissuetheories
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff.
MRI has excellent soft tissue contrast, is non-invasive, very safe, and can provide detailed images of both anatomical structure and function. These attributes are particularly appealing for human studies. However, MRI is relatively insensitive as compared to radionuclide imaging methods or optical imaging techniques. The major platforms for the development of MR "molecular imaging" contrast agents have been either Gadolinium based chelates or small iron oxide particles. Moreover, the effects of gadolinium cannot be modulated externally after the agent has been injected. The recent reports of the paramagnetic chemical exchange saturation transfer (PARACEST) effect, based on the lanthanide shift reagents, show promise that these agents offer alternatives to gadolinium based agents. Although the members of the lanthanide series have very similar chemical and toxicological properties, they have very different properties as MR contrast agents that may give them significant advantages over gadolinium based agents. These advantages are:
+ The ability to switch each agent on or off through the use of selective RF irradiation applied at the frequency of its bound water resonance can be exploited in a variety of ways. Multiple PARACEST agents can be injected and their effects imaged either sequentially or simultaneously. In their "off' state, i.e. without selective irradiation, conventional MR imaging sequences can be employed, with or without gadolinium contrast agents, because unlike gadolinium based agents, these PARACEST agents have little effect on relaxation times, T1 or T2. The ability to externally modulate the PARACEST effect can potentially improve their detection through optimized acquisition schemes described in this proposal.
+ Using chemical modifications to the chelate structures, the PARACEST agents with defined water exchange rates can be prepared based on rational chemical principles. Since the water exchange rate determines the required strength of the applied irradiation field, W1 and the RF power defined as the specific absorption rate, SAR for each PARACEST agent, the ideal PARACEST agent can be tailored to each application, i.e. body part, RF coil, and MR observation field.
+ The ability to rationally modify the water exchange rate makes PARACEST an attractive platform for the development of responsive agents.
A knowledge of lanthanide chemistry, NMR exchange theory, and practical MR considerations is necessary to fully realize and exploit these unique advantages in vivo. Theoretical and practical considerations of the PARACEST effect indicate that there will be trade-offs between water exchange rates, B1, SAR, RF coils, irradiation strategies and field strength. This project will make use of the whole body 1.5T, 3T, and 7T MR scanners available to the Resource to systematically investigate some of these effects. We have also become aware that there can be significant interference of the effects of magnetization transfer (MT) when PARACEST agents are used in vivo. We have developed three approaches to minimize these MT effects on PARACEST studies in vivo. These three approaches, which are detailed below, will be explored in collaboration with the Research Resource.
Approach 1. Chemical approach. Our chemistry group has made a very important recent discovery: water exchange in these complexes can be slowed dramatically (into the msec range) by creating DOTA-tetraamide complexes with extended phosphonate diester side chains. We already know that the Eu3+ complex of this same ligand has a very long bound water lifetime and, consequently, a very sharp PARACEST exchange peak. This will allow activation of PARACEST in the Eu3+ ligand using a much weaker RF pulse, perhaps as weak as 20-40 Hz. This in turn would be too weak for significant MT activation, and consequently the PARACEST effect would be magnified and the MT effect dramatically reduced. The Tb3+ complex has a highly shifted water peak near -500 ppm, well outside the tissue MT window. This is attractive because this agent can be activated without any confounding effects from tissue MT.
Approach 2. Positive Contrast PARACEST (PARAPCEST). Saturation of the exchanging pool during relaxation measurements results in shortening of the apparent longitudinal relaxation time, T1(app). This effect has been described historically in MR studies of chemical exchange. We have investigated the utility of this approach in both diamagnetic CEST (DIACEST) and PARACEST applications. Alternate acquisitions are carried out with the frequency of the RF saturation pulse set to the resonance of the bound water and the same frequency offset on the opposite side of water as a control. The optimization of positive PARACEST are currently being carried out as part of Elena Vinogradov's R03 (EB008183: Frequency Shifting Paramagnetic Agents: Quantitative MRI of Exchange Effects) and R21 (EB009425: Optimization of DIACEST and PARACEST methodology for quantitative in-vivo imaging). The value of TI is chosen to null out the background signal. As a result the effects of MT are almost completely suppressed. We will compare the results obtained using conventional PARACEST and PARAPCEST on EuDOTA in agar and in rats at 1.5T, 3T, and 7T in the RR.
Approach 3. Omega Plot. The Omega Plot approach is conceptually similar to the QUESP method described by McMahon et al. who used the modified Bloch equations to derive expressions relating the CEST effect to the B1 of the CEST pulse. We can extend this approach to derive an expression that can be used to generate plots which we have called Omega-plots. These Omega-plots can be used to determine k, the bound water exchange rate, without having to know the concentration of the PARACEST agent present. We will determine whether the Omega Plot approach can be employed to separate the effects of MT from the PARACEST effect in samples of EuDOTA in agar at 1.5T, 3T, and 7T in the Research Resource.
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和子项目首席研究员的主要支持可能由其他来源提供,包括NIH的其他来源。子项目列出的总成本可能代表子项目使用的中心基础设施的估计数量,而不是由NCRR授予给子项目或子项目员工的直接资金。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT E LENKINSKI其他文献
ROBERT E LENKINSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT E LENKINSKI', 18)}}的其他基金
OPTIMIZING PARACEST AGENTS FOR HUMAN MR IMAGING
优化人类 MR 成像的辅助剂
- 批准号:
8171660 - 财政年份:2010
- 资助金额:
$ 1.61万 - 项目类别:
OPTIMIZING PARACEST AGENTS FOR HUMAN MR IMAGING
优化人类 MR 成像的辅助剂
- 批准号:
7956980 - 财政年份:2009
- 资助金额:
$ 1.61万 - 项目类别:
PARACEST AGENTS: OPTIMIZATION FOR HUMAN MR IMAGING
PARACEST Agents:人类 MR 成像的优化
- 批准号:
7724130 - 财政年份:2008
- 资助金额:
$ 1.61万 - 项目类别:
PARACEST AGENTS: OPTIMIZATION FOR HUMAN MR IMAGING
PARACEST Agents:人类 MR 成像的优化
- 批准号:
7600866 - 财政年份:2007
- 资助金额:
$ 1.61万 - 项目类别:
PARACEST Agents: Optimization for Human MR Imaging
PARACEST 代理:优化人体 MR 成像
- 批准号:
8431760 - 财政年份:2006
- 资助金额:
$ 1.61万 - 项目类别:
PARACEST Agents: Optimization for Human MR Imaging
PARACEST 代理:优化人体 MR 成像
- 批准号:
7804280 - 财政年份:2006
- 资助金额:
$ 1.61万 - 项目类别:
PARACEST AGENTS: OPTIMIZATION FOR HUMAN MR IMAGING
PARACEST Agents:人类 MR 成像的优化
- 批准号:
7357909 - 财政年份:2006
- 资助金额:
$ 1.61万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 1.61万 - 项目类别:
Research Grant